Insufficient scRNA-seq data for expression of CHRDL2 at single-cell level.
Insufficient scRNA-seq data for expression of CHRDL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 76% | 1907.07 | 187 / 245 | 79% | 8.18 | 398 / 502 |
intestine | 84% | 4230.18 | 808 / 966 | 61% | 13.20 | 319 / 527 |
liver | 72% | 294.14 | 162 / 226 | 69% | 6.26 | 279 / 406 |
stomach | 65% | 4457.10 | 232 / 359 | 70% | 29.06 | 201 / 286 |
bladder | 81% | 3588.67 | 17 / 21 | 51% | 11.30 | 257 / 504 |
uterus | 95% | 8473.38 | 162 / 170 | 33% | 63.76 | 153 / 459 |
esophagus | 58% | 764.70 | 844 / 1445 | 62% | 13.14 | 114 / 183 |
heart | 87% | 1137.26 | 750 / 861 | 0% | 0 | 0 / 0 |
lung | 35% | 124.15 | 200 / 578 | 45% | 10.08 | 522 / 1155 |
pancreas | 10% | 17.47 | 32 / 328 | 58% | 10.08 | 104 / 178 |
muscle | 48% | 156.01 | 386 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 47% | 748.48 | 634 / 1335 | 0% | 0 | 0 / 0 |
breast | 22% | 190.41 | 103 / 459 | 18% | 5.05 | 203 / 1118 |
kidney | 11% | 19.57 | 10 / 89 | 17% | 1.97 | 153 / 901 |
ovary | 18% | 202.39 | 32 / 180 | 6% | 1.76 | 26 / 430 |
tonsil | 0% | 0 | 0 / 0 | 20% | 1.00 | 9 / 45 |
brain | 1% | 2.56 | 32 / 2642 | 15% | 1.10 | 105 / 705 |
skin | 5% | 13.27 | 86 / 1809 | 8% | 0.54 | 39 / 472 |
adipose | 10% | 48.74 | 122 / 1204 | 0% | 0 | 0 / 0 |
spleen | 7% | 10.61 | 16 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0.41 | 1 / 258 | 6% | 0.62 | 14 / 230 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.10 | 1 / 29 |
thymus | 2% | 6.08 | 10 / 653 | 2% | 0.05 | 10 / 605 |
eye | 0% | 0 | 0 / 0 | 1% | 0.06 | 1 / 80 |
peripheral blood | 0% | 0.45 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001503 | Biological process | ossification |
GO_0030154 | Biological process | cell differentiation |
GO_0030514 | Biological process | negative regulation of BMP signaling pathway |
GO_0051216 | Biological process | cartilage development |
GO_0005615 | Cellular component | extracellular space |
GO_0005737 | Cellular component | cytoplasm |
GO_0036122 | Molecular function | BMP binding |
Gene name | CHRDL2 |
Protein name | Chordin like 2 (Chordin-related protein 2 variant III) Chordin-like protein 2 (Breast tumor novel factor 1) (BNF-1) (Chordin-related protein 2) Chordin like 2 |
Synonyms | CHL2 BNF1 UNQ765/PRO1557 |
Description | FUNCTION: May inhibit BMPs activity by blocking their interaction with their receptors. Has a negative regulator effect on the cartilage formation/regeneration from immature mesenchymal cells, by preventing or reducing the rate of matrix accumulation (By similarity). Implicated in tumor angiogenesis. May play a role during myoblast and osteoblast differentiation, and maturation. . |
Accessions | A8MQ10 ENST00000376332.8 [Q6WN34-1] Q6WN34 ENST00000525413.5 ENST00000529912.5 H0YDT1 ENST00000263671.9 [Q6WN34-2] ENST00000528789.1 ENST00000534276.5 [Q6WN34-4] H0YCU0 Q6WN33 ENST00000528471.1 [Q6WN34-5] ENST00000376324.7 |